The global proteomics market size accounted for USD 36.25 billion in 2024, grew to USD 41.65 billion in 2025 and is predicted to surpass around USD 145.39 billion by 2034, representing a healthy CAGR of 14.90% between 2024 and 2034. The North America proteomics market size is calculated at USD 17.04 billion in 2024 and is expected to grow at a fastest CAGR of 15.01% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Proteomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Proteomics Market, by Product, 2024-2034
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Consumables and reagents
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Proteomics Market, by Application, 2024-2034
9.1.1. Drug Discovery
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Clinical Diagnostics
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Proteomics Market, by Technology, 2024-2034
10.1.1. Spectroscopy
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Microarray instruments
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Chromatography
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. X-ray crystallography
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Protein Microarrays
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Electrophoresis
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Protein fractionation system
10.1.7.1. Market Revenue and Forecast (2021-2034)
10.1.8. Surface plasma resonance systems
10.1.8.1. Market Revenue and Forecast (2021-2034)
11.1. Proteomics Market, by Software & Service, 2024-2034
11.1.1. Core Proteomics Services
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Bioinformatics Software & Services
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Proteomics Market, by End User, 2024-2034
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Clinical Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Pharmaceutical Companies
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Academic Research Laboratories
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.7. Market Revenue and Forecast, by Software & Service (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.10. Market Revenue and Forecast, by Software & Service (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Software & Service (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. Thermo Fisher scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Alumna incorporated
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Creative proteomics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. GE healthcare
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Integrated proteomics applications
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample